I briefly looked at the Q2 financial statement. It looks like gross revenue was up about a billion (12.9 b) for the quarter (still down from 15.3b YOY). But in addition to the Q1Q2 revenue increase YOY R&D and MG&A (grouped together) was down to 5.5 billion from 6.2 Q2 22. The net income was at 1.5 billion so it looks like a combination of reduced spending and increased revenue created the net 1.5b profit. Because they group MG&A and R&D together it is difficult to say if they are actually slowing down R&D or simply didn't have loss charges from bad acquisitions that they were trying to get off of the books though so some of that is like playing poker.